Presentation ISET 2015 Massive and Submassive PE: Rationale for Changing Treatment Paradigm Presenter: Victor F. Tapson February 01, 2015
Presentation VEINS 2014 Antiplatelets and Anticoagulation Post Intervention: Surveillance and Predictors of Failure Presenter: Nicolas W. Shammas October 10, 2014
News Daily News Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE L.A. McKeown January 27, 2014
News Daily News Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients Yael L. Maxwell January 01, 2014
News Daily News Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV Yael L. Maxwell January 01, 2014
News Daily News Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin Jason Kahn October 04, 2013
News Conference News ESC 2013 Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients Caitlin E. Cox September 02, 2013
News Daily News Nuevas Evidencias Desacreditan la Hipótesis Venosa en la Esclerosis Múltiple Yael L. Maxwell August 19, 2013
News Daily News Further Evidence Discredits Venous Hypothesis in Multiple Sclerosis Yael L. Maxwell August 19, 2013
Presentation Evidence Against the Involvement of Chronic Cerebrospinal Venous Abnormalities in MS Presenter: I. Rodger August 15, 2013
News Daily News El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos L.A. McKeown July 05, 2013
News Daily News Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism L.A. McKeown July 05, 2013
News Daily News Stent Grafts Better Than Angioplasty for Failing Dialysis-Access Grafts Jason Kahn April 19, 2013
News Daily News Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years Caitlin E. Cox July 12, 2012
News Daily News Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD June 25, 2012